December 1, 2014 News by Patricia Silva, PhD FDA Delays Ruling on Teva Petition Against Generic Copaxone for MS Teva Pharmaceutical Industries Ltd., the company behind multiple sclerosis drugĀ COPAXONEĀ® (glatiramer acetate injection), has been pursuing the US Food and Drug Administration‘s decision against approving a generic version of the drug, by Mylan, Inc.Ā Teva’s petition has been turned down several times,…
December 1, 2014 News by Patricia Inacio, PhD New Insights Into “T Helper Cells” Could Guide Future Multiple Sclerosis Therapies A recent study entitled āSTAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammationā describes a new subset of T helper immune cells ā TH-GM ā thatĀ express a particular cytokine profile with implications inĀ therapeutics for multiple sclerosis. The study was…